Brief report · 29 Dec 2025
Review articlePublished 2012
Antidiabetic Effects of Ginseng in Humans and Rodents
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Ginseng, one of the most commonly used herbs worldwide, has known anti-hyperglycemic effects. Twenty-eight (28) studies on diabetic mice and rats from 7 research centers (in 6 different nations) indicate that both Asian ginseng (Panax ginseng) and American ginseng (Panax quinquefolius) are effective anti-hyperglycemic supplements, putatively acting via improvements in insulin secretion, insulin sensitivity, islet protection, obesity reduction, antioxidation, energy expenditure, and fat absorption. Investigations in clonal beta-cells (MIN6, RINmF, INS-1, HIT-T15) and non-beta-cells (3T3-L1, C1C12, HepG2) further confirm that ginseng may protect against pancreatic beta-cell apoptosis and promote insulin secretion and glucose uptake. Among 18 human trials from 4 independent groups, 15 are single dose trials; whereas, 4 are long-term trials, with treatment periods lasting longer than 4 weeks. Eleven of the single dose trials observed anti-diabetic effects, while 4 observed no improvements. In the long-term studies, two-thirds of the studies on type 2 diabetic (T2D) patients observed anti-hyperglycemic effects. Based upon the sound evidence from cell lines and animal models, along with the improvements from the majority of human subject trials, ginseng appears to be a potent anti-diabetic supplement. Regardless, more long-term trials on T2D patients are required before ginseng can be safely recommended as a broadly-used anti-diabetic agent.
Keywords
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Metabolic Syndrome.
Commentary · 29 Dec 2025
Type 2 Diabetes: Advances in Management and Etiology
Commentary · 29 Dec 2025
Evolving T2DM Management: Novel Therapies, Holistic Care
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Metabolic Syndrome
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Zhanxiang Wang”
- BylineArticles whose byline prints “Hongji Zhang”
